Clinical Update: Glaucoma
Overlap Syndrome: The Multiple Factors of Multiple Glaucomas
By Miriam Karmel, Contributing Writer
Your glaucoma patient has long been stable on pressure-lowering therapy. So
how do you now explain a sudden spike in pressure and new progression of
visual field loss? Before changing the medication or blaming patient
noncompliance, you might want to consider what Robert Ritch, MD, calls
³overlap syndrome.²
Overlap gives name to the situation in which the patient with glaucoma
develops a newand differentglaucoma risk factor that can speed
glaucomatous damage. Overlap can also be used to describe the coexistence of
two or more frank glaucomas in one eye, each of which may have a distinct
etiology, time of onset, presentation and clinical course. Recognizing
overlap conditions allows for new ways of treating patients, particularly
those with secondary and normal-tension glaucomas.
Dr. Ritch, who is a professor of clinical ophthalmology and chief of the
glaucoma service and surgery director at the New York Eye and Ear Infirmary,
said, ³Basically, if you have a patient with glaucoma who has been
well-controlled and clicking along for some time, and then all of a sudden
either the pressure goes up in one eye or a visual field destabilizes, that
suggests the development of a second condition superimposed on the
glaucoma.²
Explaining Overlap
The overlap concept was first introduced in 1990, in a report of five
middle-aged patients with increasingly uncontrollable IOP.1 All patients had
exfoliation syndrome (XFS) and were then found to have had pigment
dispersion syndrome (PDS) as well.
Following that report, Dr. Ritch and colleagues conducted a retrospective
chart review of records at New York Eye and Ear Infirmary, and identified an
additional 26 patients who had combined PDS/XFS. 2, 3 Those two glaucomas
have no known etiologic relationship.
XFS is the most common identifiable disorder leading to the development of
open-angle glaucoma worldwide, and it constitutes about 12 percent of
glaucoma in the United States, where the combination could affect up to half
a million individuals. In the context of PDS/ XFS, the overlap theory
explains why patients with previous pigment dispersion syndrome who go on to
develop exfoliation may be more susceptible to elevated IOP than patients
with XFS who have not had PDS. The reason: preexisting damage to the
trabecular meshwork.
Helpful model. While there can be other overlap combinations, PDS/XFS was
chosen as a paradigm for the syndrome because of the ease of diagnosis and
its prevalence. ³Itıs easy and straightforward to look at patients who have
clinical evidence of PDS and pseudoexfoliation,² said Raghu Mudumbai, MD, a
coauthor of the overlap studies and assistant professor of ophthalmology, at
the University of Washington, Seattle.
Dr. Mudumbai reiterated Dr. Ritchıs definition of overlap glaucomas. ³In
patients whose glaucoma is decompensating, and itıs not an effect of the
medication not working as well, or the patient not being compliant, perhaps
itıs a third possibilitythat a new comorbidity has been introduced that has
exacerbated the underlying glaucoma.²
Not necessarily obvious. Some overlap combinations, in fact, may not be
readily apparent to the ophthalmologist, Dr. Mudumbai said. For example,
after developing glaucoma, a patient may develop another risk factor that
may not be as self-evident as pseudoexfoliation, but which may nevertheless
contribute to the decompensation of the patientıs glaucoma. ³Overlap
syndrome is a two-hit hypothesis,² he continued. ³One hit is your initial
glaucoma process that causes some damage and some difficulty with pressure
control, for example. Youıve been able to manage it fairly well with
medication. But now, you introduce a second problem that overwhelms the
system and as a result of that, decompensation takes place.² The second hit
could be the appearance of XFS in patients who previously had pigmentary
dispersion syndrome, or it may be a pressure-independent process.
Pigment, pigment everywhere. ³Overlap is a useful concept about which
ophthalmologists need to be aware,² said Donald S. Minckler, MD, professor
of ophthalmology and pathology, University of California, Irvine. Dr.
Minckler said that the PDS/XFS combination, as described by Drs. Ritch and
Mudumbai, provides a very good basis for establishing the concept of
overlap. ³The important point is that patients with pigmentary dispersion
with or without glaucoma have pseudoexfoliation-associated risks added to
those of pigmentary dispersiona double whammyprobably with a worse
prognosis,² he said. ³Common sense dictates that the physician should watch
for pseudoexfoliation to appear in pigmentary dispersion patients. Since we
only see what we are looking for, being aware of the possibility is
important for the small percentage of such patients whom we might
encounter.²
Take care in the OR (and the gym). Another example, Dr. Minckler said, is a
patient with open-angle glaucoma whofor various reasons, sometimes ocular
surgerydevelops progressive angle closure with a significant change in
symptoms. ³I have also rarely encountered patients without typical pigment
dispersion who developed remarkable IOP rise postcataract surgery, probably
provoked by intraocular manipulations and resulting in iris pigment release,
with obstruction of outflow channels. Such pigment stormsı can be confused
with uveitis and can also occur in rare cases after vigorous exercise in
patients with pigmentary dispersion syndrome.²
Borrowing From Beyond the Eye
Thereıs precedent for looking beyond any single etiology for a particular
pathology, said Dr. Mudumbai, noting that cardiovascular disease provides an
example to support the overlap syndrome. ³Who ever would have thought that
tooth cavities or gum disease would be related to cardiovascular disease?
But itıs been shown that having poor dental health can lead to inflammatory
factors that can lead to cardiovascular disease.²
The cardiovascular example, which involves factors not typically related to
heart disease, suggests that ophthalmologists who concentrate solely on IOP
might not be able to control the glaucoma if they neglect to consider
pressure-independent risk factors.
IOP not always revealing. When he elaborated the concept for Eye M.D.s at a
1999 meeting of the American Ophthalmological Society, Dr. Ritch told
colleagues, ³We are entering an era in which we are becoming more aware of
the existence of an ever increasing list of nonpressure-dependent risk
factors for glaucomatous damage.² The risk factors he cited included: atrial
fibrillation, vasospastic or autoregulatory disorders, nocturnal
hypertension, abnormal platelet aggregation, hemorheologic abnormalities,
sleep apnea and autoimmune phenomema. The development of one of those
non-IOP-dependent risk factors may cause the sudden acceleration of
glaucomatous damage.
³If somebodyıs been controlled for a long time and then goes out of control,
donıt just juggle the medications,² Dr. Ritch said. ³You have to look for a
new kind of glaucoma starting up, or a non-IOP related risk factor. Look for
something new thatıs developed.²
Advice to clinicians. Dr. Mudumbai agreed. The sudden decompensation should
be a red flag, he said. ³You should at least go through the mental process
of seeing whether another problem has been introduced thatıs feeding into
the change thatıs occurred.²
Donıt doctors ordinarily do that? ³They do,² Dr. Mudumbai said. ³But you
should be more in tune for the possibility that another process may be going
on that is affecting the patientıs glaucoma. Itıs fairly easy to say, Okay,
the medicationıs not working; I need to add another medication,ı as opposed
to saying, Maybe something else is happening. Maybe I should look again for
pseudoexfoliation.ı²
Dr. Ritch added that a better understanding of the etiology of new risk
factors is required before appropriate treatments can be devised. In the
meantime, he said that thinking in terms of overlap can form the basis for
³understanding the sequential appearance of various risk factors over the
course of the life of a patient with glaucoma.²
In their 2000 Ophthalmology report, Drs. Ritch and Mudumbai expressed hope
that awareness of newly arisen risk factors ³will stimulate both a search
for the specific causes in a particular patient workup and interdisciplinary
investigations to identify these risk factors, with the goal of expanding
our therapeutic armamentarium.²